Bio-Rad Laboratories Inc. (BIO) Tops Q2 EPS by 50c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $361.19 --0%
Financial Fact:
Provision for income taxes: -8.85M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Provision for income taxes: -8.85M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q2 EPS of $1.69, $0.50 better than the analyst estimate of $1.19. Revenue for the quarter came in at $510.4 million versus the consensus estimate of $526.16 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
